Paired with Inder Sran's electrifying performance, seamlessly blending rap and melody, 'Ridin Dirty' offers viewers an ...

The Bookseller is the incisive and independent source of news and analysis for the book trade and publishing industry. Get ...

Analyst Joseph Vruwink of Robert W. Baird maintained a Buy rating on PTC (PTC – Research Report), retaining the price target of $210.00.

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on April 19, 2024, the company approved non-statutory stock options to purchase an aggregate of 8,090 shares of its common stock and 8,290 ...

Boston-based software company PTC (PTC) was in focus on Tuesday as investment firm Baird maintained its Outperform rating ...

The robotics industry is expected to reach $95.93 billion by 2029, growing at a CAGR of 15.91%. Robotics has become more ...

In a letter addressed to SSP Sushil Chandrabhan Ghule this week, Diwakar expressed deep concern over the threatening calls ...

Discover the latest patent from PTC Therapeutics Inc for treating Huntington's disease with innovative compounds and pharmaceutical compositions. Learn more about the groundbreaking Formula (I) and ...

PTC has been exporting cigarettes to numerous world markets since 2019 and has so far earned $156 million for the country.

PTC's revenue growth durability relies on cross-selling and upselling to its existing client base. See why we're bearish on ...

Manufacturers are expanding U.S. production capacity to meet rising demand but tax credits favour some American components ...